Acyclovir

Acyclovir

SCHEMBL40723

Nc1nc(=O)c2ncn(COCCO)c2[nH]1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNP P00491 9/20 0.67
BLM P54132 2/20 0.67
HBB P68871 2/20 0.67
USP2 O75604 1/20 0.67
TSHR P16473 1/20 0.67
EDNRA P25101 1/20 0.67
HTR2A P28223 1/20 0.67
RECQL P46063 1/20 0.67
HSD17B10 Q99714 1/20 0.67
HPRT1 P00492 3/20 0.52
TK1 P04183 2/20 0.49
POLG P54098 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
CYP3A4 P08684 1/20 0.46
NFKB1 P19838 1/20 0.46
VCP P55072 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1477723 0.84 PNP (0.61) PNPBLMHBBUSP2TSHR
SCHEMBL18190780 0.84 PNP (0.47) PNPBLMHBBUSP2TSHR
Penciclovir SCHEMBL5171433 0.83 PNP (0.70) PNPBLMHBBUSP2TSHR
SCHEMBL28123382 0.81 TK1 (0.60) PNPBLMHBBUSP2TSHR
Ganciclovir SCHEMBL3034 0.81 BLM (0.67) PNPBLMHBBUSP2TSHR
Acyclovir SCHEMBL3664893 0.81 PNP (1.00) PNPBLMHBBUSP2TSHR
Acyclovir SCHEMBL2269160 0.81 PNP (1.00) PNPBLMHBBUSP2TSHR
Acyclovir SCHEMBL3175 0.81 PNP (1.00) PNPBLMHBBUSP2TSHR
SCHEMBL23948433 0.80 KMT2A (0.53) PNPBLMHBBUSP2TSHR
Valacyclovir SCHEMBL34375 0.80 KMT2A (0.72) PNPBLMHBBUSP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 15593 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3607938-B1 PHARMACEUTICAL COMPOSITION SOVIC BRKICIC LJILJANA (HR) 2026-05-27 EP claimed
US-20260139860-A1 PRODUCTS OF MANUFACTURE FOR THE TREATMENT, PREVENTION AND AMELIORATION OF MICROBIAL INFECTIONS CENTRE FOR DIGESTIVE DISEASES (AU) 2026-05-21 US claimed
WO-2026107412-A1 SARCOSPAN MODULATION AND METHODS OF MEAT AND TISSUE CULTURE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2026-05-21 WO claimed
EP-4255391-B1 LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION METRIOPHARM AG (CH) 2026-05-06 EP claimed
US-20260108619-A1 CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS HANGZHOU DAC BIOTECH CO., LTD. (CN) 2026-04-23 US claimed
EP-3790536-B1 NANOCONTAINERS FOR TRANSPORTING NONPOLAR, LIPOPHILIC SUBSTANCES SUCH AS ANTIBIOTICS KARLSRUHER INST TECHNOLOGIE (DE) 2026-04-22 EP claimed
EP-3534910-B1 RIFAMPICIN DERIVATIVES WITH ANTIBACTERIAL ACTIVITY POP TEST ONCOLOGY LLC (US) 2026-03-25 EP claimed
US-20260076872-A1 POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME SIO2 MEDICAL PRODUCTS LLC (US) 2026-03-19 US claimed
US-12576124-B2 Formulation of a conjugate of a tubulysin analog to a cell-binding molecule HANGZHOU DAC BIOTECH CO., LTD (CN) 2026-03-17 US claimed
US-20260060964-A1 METHODS AND COMPOSITIONS FOR TREATING SEPSIS ANTIVIRUS THERAPEUTICS (US) 2026-03-05 US claimed
EP-0454773-A1 NOVEL PRODRUG DERIVATIVES OF BIOLOGICALLY ACTIVE AGENTS CONTAINING HYDROXYL GROUPS OR NH-ACIDIC GROUPS Bundgaard, Hans (DK) 1991-11-06 EP claimed
WO-1990008128-A1 NOVEL PRODRUG DERIVATIVES OF BIOLOGICALLY ACTIVE AGENTS CONTAINING HYDROXYL GROUPS OR NH-ACIDIC GROUPS BUNDGAARD HANS (DK) 1990-07-26 WO claimed
US-4902678-A SYNERGISTIC MIXTURE; HERPES VIRUS INFECTIONS SYNTEX (U.S.A.) INC. (US) 1990-02-20 US claimed
EP-0287210-A2 Therapeutic compositions MEDICAL RESEARCH INTERNATIONAL LIMITED (GB) 1988-10-19 EP claimed
EP-0101441-B1 ANTI-VIRAL COMPOSITIONS SYNTEX (U.S.A.) INC. (US) 1987-01-14 EP claimed
EP-0101441-A4 ANTI-VIRAL COMPOSITIONS. ENS BIO LOGICALS INC (CA) 1985-04-11 EP claimed
EP-0101441-A1 ANTI-VIRAL COMPOSITIONS. ENS BIO LOGICALS INC (CA) 1984-02-29 EP claimed
EP-0090837-A1 METHOD AND COMPOSITION FOR TREATING A PATIENT SUFFERING FROM INTERFERONSUSCEPTIBLE DISORDER BERG, Kurt Frimann (DK) 1983-10-12 EP claimed
WO-1983002723-A1 ANTI-VIRAL COMPOSITIONS SMITH, KENDALL, O. 1983-08-18 WO claimed
WO-1983001198-A1 METHOD AND COMPOSITION FOR TREATING A PATIENT SUFFERING FROM INTERFERON-SUSCEPTIBLE DISORDER BERG, KURT, FRIMANN 1983-04-14 WO claimed